Your browser doesn't support javascript.
loading
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
Yurdaydin, Cihan; Keskin, Onur; Yurdcu, Esra; Çaliskan, Aysun; Önem, Soner; Karakaya, Fatih; Kalkan, Çagdas; Karatayli, Ersin; Karatayli, Senem; Choong, Ingrid; Apelian, David; Koh, Christopher; Heller, Theo; Idilman, Ramazan; Bozdayi, A Mithat; Glenn, Jeffrey S.
Afiliación
  • Yurdaydin C; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey.
  • Keskin O; Hepatology Institute, University of Ankara, Ankara, Turkey.
  • Yurdcu E; Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey.
  • Çaliskan A; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey.
  • Önem S; Hepatology Institute, University of Ankara, Ankara, Turkey.
  • Karakaya F; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey.
  • Kalkan Ç; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey.
  • Karatayli E; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey.
  • Karatayli S; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey.
  • Choong I; Hepatology Institute, University of Ankara, Ankara, Turkey.
  • Apelian D; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
  • Koh C; Hepatology Institute, University of Ankara, Ankara, Turkey.
  • Heller T; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
  • Idilman R; Eiger BioPharmaceuticals, Inc., Palo Alto, California, USA.
  • Bozdayi AM; Eiger BioPharmaceuticals, Inc., Palo Alto, California, USA.
  • Glenn JS; Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Hepatology ; 75(6): 1551-1565, 2022 06.
Article en En | MEDLINE | ID: mdl-34860418

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Hepatitis D Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Hepatitis D Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos